Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
29.02
+0.44 (1.54%)
At close: Mar 27, 2026

Giant Biogene Holding Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30,81135,46750,36034,74632,794-
Market Cap Growth
-56.93%-29.57%44.94%5.95%--
Enterprise Value
21,56825,77743,85131,75031,531-
Last Close Price
29.0233.2848.7834.0932.18-
PE Ratio
14.4116.6422.9521.7341.68-
Forward PE
13.9312.6119.6619.7126.93-
PS Ratio
5.025.788.548.9512.27-
PB Ratio
2.793.216.657.2210.23-
P/TBV Ratio
2.793.226.667.2410.26-
P/FCF Ratio
--26.3722.1937.24-
P/OCF Ratio
--23.1819.1431.14-
EV/Sales Ratio
3.514.207.448.1811.80-
EV/EBITDA Ratio
8.9110.7017.7217.5424.07-
EV/EBIT Ratio
9.1010.9218.0617.8824.61-
EV/FCF Ratio
--22.9620.2835.80-
Debt / Equity Ratio
0.000.000.000.000.00-
Debt / EBITDA Ratio
0.000.000.000.000.00-
Debt / FCF Ratio
--0.000.000.00-
Net Debt / Equity Ratio
-0.84-0.84-0.82-0.87-0.78-7.14
Net Debt / EBITDA Ratio
-3.84-3.84-2.52-2.31-1.91-7.78
Net Debt / FCF Ratio
---3.27-2.66-2.84-11.76
Asset Turnover
0.590.590.850.870.430.30
Inventory Turnover
3.093.093.883.002.702.57
Quick Ratio
10.7010.707.217.368.161.07
Current Ratio
11.2711.277.667.799.031.09
Return on Equity (ROE)
22.47%22.47%35.88%40.18%51.98%112.30%
Return on Assets (ROA)
14.04%14.04%21.92%24.84%12.86%10.81%
Return on Invested Capital (ROIC)
107.58%121.07%208.92%221.93%--
Return on Capital Employed (ROCE)
21.10%21.10%31.70%36.30%39.70%88.00%
Earnings Yield
6.92%6.01%4.36%4.60%3.45%-
FCF Yield
--3.79%4.51%2.69%-
Dividend Yield
4.73%1.80%1.31%1.42%--
Payout Ratio
--44.05%-36.67%307.92%
Buyback Yield / Dilution
-5.76%-5.76%-1.93%3.77%-2.03%-0.09%
Total Shareholder Return
-1.03%-3.96%-0.62%5.19%-2.03%-0.09%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.